MIRM compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

MIRMMirum Pharmaceuticals, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

MIRMMirum Pharmaceuticals, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only MIRM 14

PFEPfizersupplier

SNYNFSanofi-Aventis Deutschland GmbHsupplier

—Bluejay Therapeuticsunlistedsupplier

—Dart Neuroscienceunlistedsupplier

10 more · MIRM chain ›

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

MIRMMirum Pharmaceuticals, Inc.

93.49· pre 93.07· delayed

Mkt cap$6.1BRevenue$186MQ3 FY26Revenue$521MFY25

LLYELI Lilly & Co

1,371.32· pre 1,350.00· delayed

Pre-marketNov 6 '26delayed

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Pre-marketNov 6 '26delayed

MIRMMirum Pharmaceuticals, Inc.

LLYELI Lilly & Co

93.49pre 93.07delayed

Price

1,371.32pre 1,350.00delayed

$6.1B

Mkt cap

$1.2T

Q3 FY26$186M

Revenue

$24.4BQ3 FY26

FY25$521M

Revenue

$65.2BFY25

MIRM93.49vsLLY1,371.32Pre-marketNov 6 '26delayed